Respiratory Care Devices Market
Respiratory Care Devices Market Forecast to 2030
The Global Respiratory Care Devices Market research report is a complete document that explains the most recent breakthroughs and advancements in the Respiratory Care Devices industry, using 2019 as the base year and 2022–2030 as the forecast year. The analysis offers insightful data on the market’s size, share, sales channels, distribution networks, market segmentation, consumer demands and trends, and growth prospects. The expansion of regional and global markets is also examined in the study. In the paper, the effect of the COVID-19 pandemic on the market for Respiratory Care Devices and its important sectors is studied.
The global respiratory care devices market size is expected to reach USD 38.67 billion in 2030 at a steady revenue CAGR of 8.5% during the forecast period, according to the latest analysis by Emergen Research. One of the primary factors driving revenue growth in the market is the rising prevalence of preterm births. Every year, an estimated 15 million infants are born prematurely; that is more than one in every ten infants. Every year, around 1 million children die as a result of preterm delivery problems. Many survivors would be disabled for the rest of their lives, including those with learning difficulties and vision and hearing issues. The bulk of premature births occur in Africa and southern Asia; however, preterm birth is a worldwide issue. Premature newborns frequently experience respiratory distress syndrome (RDS). It can cause newborns to require more oxygen and assistance with breathing. As a result, demand for effective respiratory care devices is expected to rise, driven by an increase in preterm births.
Request a Sample Report with Table of Contents and Figures to visit this site @ https://www.emergenresearch.com/request-sample/1657
The global Respiratory Care Devices market report employs an extremely extensive and perceptive process that analyzes statistical data relating to services and products offered in the market. The research study is a pivotal document in understanding the needs and wants of the clients. The report is comprised of significant data about the leading companies and their marketing strategies. The Respiratory Care Devices industry is witnessing an expansion and change of dynamics owing to the entry of several new players.
The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.
ResMed, NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., Masimo, Fisher & Paykel Healthcare Limited, Getinge AB, Medtronic plc, General Electric Company, VYAIRE, and Drägerwerk AG & Co. KGaA
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends @ https://www.emergenresearch.com/industry-report/respiratory-care-devices-market
Some Key Highlights From the Report
On 16 August 2021, ResMed, which is a maker of connected sleep devices, revealed the AirSense 11, its newest CPAP machine version, which has a plethora of new features for treating obstructive sleep apnea. ResMed is launching the AirSense 11 initially in the U.S., with ambitions to expand. It is said to be compatible with all of the company’s existing masks.
The therapeutic respiratory care devices segment is expected to account for largest revenue share during the forecast period, owing to rising government healthcare spending, increased use of various therapeutic devices in home care settings, rapid urbanization, and rising levels of air pollution. The Ontario government, for example, is supporting a USD 2.9 million investment by five local enterprises to increase domestic medical supply manufacture and support the development of indigenous solutions to help reduce the spread of COVID-19. Through the Ontario Together Fund (OTF), the province is providing more than USD 1.54 million.
The Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for largest revenue share during the forecast period, which is attributed to increased prevalence of smoking, tobacco smoke exposure, adverse climatic conditions and a high frequency of lower respiratory illnesses. For example, 12.5% of adults in the U.S. (an estimated 30.8 million individuals) smoked cigarettes in 2020: 14.1% of men and 11% of women. Over 7 million deaths are due to direct tobacco use, whereas approximately 1.2 million are caused by nonsmokers being exposed to second-hand smoke. Over 80% of the world’s 1.3 billion smokers are in low- and middle-income countries. Rising prevalence of smoking and environmental conditions is driving revenue growth of the segment.
The market in Europe is expected to register a steady revenue CAGR during the forecast period, owing to increased investment and initiatives by major market leaders. On 23 November 2022 for example, LifeArc funded up to USD 12.2 million in up to five cooperative studies to repurpose existing drugs and chemicals as innovative therapies for bronchiectasis and cystic fibrosis. The collaboration opportunity is the first significant funding opportunity announced as part of LifeArc’s new USD 122.9 million Chronic Respiratory Infection Translational Challenge, which seeks to accelerate scientific innovation for individuals living with bronchiectasis and cystic fibrosis.
Market Overview:
The report bifurcates the Respiratory Care Devices market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
Product Outlook (Revenue, USD Billion; 2019–2030)
Therapeutic Respiratory Care Devices
PAP Devices
CPAP Devices
APAP Devices
BiPAP Devices
Ventilators
ICU Ventilators
High-End Ventilators
Mid-End Ventilators
Basic Ventilators
Portable Ventilators
Nebulizers
Humidifiers
Heated Humidifiers
Passover Humidifiers
Oxygen Concentrators
Fixed Oxygen Concentrators
Portable Oxygen Concentrators
Inhalers
Metered-Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Reusable Resuscitators
Nitric Oxide Delivery Units
Oxygen Hoods
Monitoring Devices
Pulse Oximeters
Pulse Oximeter Sensors
Pulse Oximeter Equipment
Capnographs
Gas Analyzers
Diagnostic Respiratory Care Devices
Spirometers
Polysomnography Devices (PSG Devices)
Peak Flow Meters
Others
Consumables & Accessories
Masks
Reusable Masks
Disposable Masks
Disposable Resuscitators
Tracheostomy Tubes
Breathing Circuits
Nasal Cannulae
Others
Disease Indications Outlook (Revenue, USD Billion; 2019–2030)
Chronic Obstructive Pulmonary Disease (COPD)
Sleep Apnea
Asthma
Infectious Diseases
Others
End-use Outlook (Revenue, USD Billion; 2019–2030)
Hospitals
Home Care Settings
Ambulatory Care Centers
The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market.
Regional Analysis Covers:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Furthermore, the report provides the analytical data in an organized format segmented into charts, tables, graphs, figures, and diagrams. This enables readers to understand the market scenario in an easy and beneficial manner. Moreover, the report aims to impart a prospective outlook and draw an informative conclusion to assist the reader in making lucrative business decisions. The report, in conclusion, provides a detailed analysis of the segments expected to dominate the market, the regional bifurcation, the estimated market size and share, and comprehensive SWOT analysis and Porter’s Five Forces Analysis.
Thank you for reading our report. For further queries, please connect with us, and our team will provide you the report best suited to your requirements.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
